PETS(PetMed Express, Inc.) · 财务报表

PETS(PetMed Express, Inc.) 的财务报表:医疗保健,药品零售。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2022-03-31FY 截至 2023-03-31FY 截至 2024-03-31FY 截至 2025-03-31FY 截至 2026-03-31
营业收入$272.28M$247.57M$274.10M$226.97M$179.02M
毛利润$76.94M$76.50M$84.77M$69.14M$50.22M
营业利润$24.29M$6.05M−$8.16M−$1.53M−$58.67M
净利润$18.72M$5.14M−$7.46M−$6.27M−$57.29M
经营现金流$18.50M$27.80M$4.32M$4.72M−$28.39M
自由现金流$16.75M$22.54M−$194.00K−$395.00K−$33.01M
摊薄每股收益$0.92$0.25$-0.37$-0.30$-2.74

PetMed Express, Inc. PETS